Work

Is one year enough? Extended adjuvant dabrafenib plus trametinib for Chinese patients with resected stage III melanoma.

Year: 2025

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e21587

Authors: Dong-Dong Jia, Tao Li, Jilong Yang, Yong Chen

Institutions: Zhejiang Cancer Hospital, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Fudan University Shanghai Cancer Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410804560

Cites:

Cited by:

Related to: 10